4//SEC Filing
Khosrovi Behzad 4
Accession 0001437749-12-001705
CIK 0001389545other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:31 PM ET
Size
5.2 KB
Accession
0001437749-12-001705
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2012-02-17+52,083→ 486,283 totalExercise: $1.44From: 2012-03-30Exp: 2022-02-17→ Common Stock (52,083 underlying)
Footnotes (1)
- [F1]The options will vest and become exercisable in four equal installments: Twenty-five percent (25%) each on March 30, 2012, June 30, 2012, September 30, 2012 and December 30, 2012.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:31 PM ET
- Size
- 5.2 KB